Legionella bacteria can cause a serious type of pneumonia called Legionnaires’ disease. It is commonly found in water, and people can get sick when they breathe in mist or accidentally swallow water containing the bacteria. Legionella testing helps detect the presence of these bacteria, which allows necessary preventive measures.
The global Legionella Testing Market is estimated to be valued at US$ 1,864.07 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing concerns regarding waterborne diseases is projected to drive the growth of the legionella testing market over the forecast period. Legionella bacteria commonly found in water systems such as cooling towers, hot tubs, humidifiers, hot water tanks, and plumbing systems and people can get infected when they breathe in mist or vapor from these contaminated water sources. According to the Centers for Disease Control and Prevention (CDC), each year around 8,000 to 18,000 people in the United States get infected with Legionella and around 1,000 people die from Legionnaires’ disease. Hence, regular testing of water sources helps in the early detection of Legionella bacteria and prevents the outbreak of waterborne diseases. This is expected to augment the demand for legionella testing over the forecast period.
Strength: Legionella testing helps in early diagnosis and treatment of Legionnaires’ disease. Detection of Legionella bacteria helps curb outbreaks and prevents further infection.
Weakness: Traditional culture-based methods for Legionella testing are time-consuming and require 5-10 days for results. New molecular diagnostic methods are costly.
Opportunity: Growing awareness about waterborne diseases and regulation mandating regular testing of water systems in hospitals, hotels, and industrial facilities creates market opportunity.
Threats: Alternative technologies like PCR-based testing gaining popularity pose competition. Economic slowdowns can impact overall healthcare spending and affect testing volumes.
The global Legionella testing market is expected to witness high growth.
Regional Analysis: Rapid urbanization and infrastructure development activities especially in Asia Pacific region augment the demand for Legionella testing. Countries like China, India, and Japan are witnessing rapid construction of buildings, hotels, hospitals and other commercial complexes which requires periodic testing of water systems as per regulations. This drives the Legionella testing market in the region.
Key players operating in the Legionella testing market are Boston Scientific Corporation, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Medical, B. Braun Melsungen AG, Medtronic Plc., Novo Nordisk A/S, SERAG-WIESSNER GmbH & Co., Smithâ€TMs Medical, Terumo Corporation, Stryker Corporation, and NIPRO Medical Corporation. Traditional culture-based tests are being replaced by new molecular diagnostic techniques like PCR, IFA, and others due to their faster results. However, high costs of newer tests compared to conventional methods can hamper full adoption. Companies are focused on developing cost-effective rapid tests to increase accessibility and testing volumes.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it